Observational cohort for patients with uveitis and spondyloarthritis
Official title: Assessment of Spondyloarthritis in an Acute Anterior Uveitis Inception Cohort: a Cross Sectional and Prospective Comparative Study of HLA-B27-positive and -negative Cases
Run by Marmara University · NCT06720376 · Data updated 2026-11-12
This study is tracking patients with uveitis to see how it relates to spondyloarthritis and to learn more about their symptoms and treatment options.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Marmara University Academic / other |
| Locations | 1 site (Istanbul, Maltepe) |
| Status | Recruiting |
| Started | January 15, 2023 |
| Main results expected | January 15, 2028 |
| Study ends | January 15, 2030 |
| Registry record updated | December 6, 2024 |
| Trial ID | NCT06720376 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients currently diagnosed with uveitis.
✕Probably not a fit
Patients who have been previously diagnosed with spondyloarthritis before the onset of uveitis or those with infectious uveitis may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational cohort aims to gather data on patients with uveitis and spondyloarthritis to better understand the relationship between these conditions. The study will track the clinical features, diagnostic criteria, and disease management strategies employed for these patients. By utilizing imaging techniques and clinical assessments, researchers hope to identify patterns and outcomes that can inform future treatment approaches. The cohort will include patients diagnosed with uveitis, while excluding those with prior spondyloarthritis diagnoses or infectious uveitis.
Why it matters
Potential benefit: If successful, this study could enhance understanding of the interplay between uveitis and spondyloarthritis, leading to improved diagnostic and treatment strategies for affected patients.
How similar studies have gone: While there have been studies on spondyloarthritis and uveitis separately, this specific observational cohort approach is relatively novel and untested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients with uveitis Exclusion Criteria: * patients diagnosed spondyloarthiritis before from the uveitis attack * patients with infectious uveitis
Where it's running
-
Marmara University School of Medicine
Istanbul, Maltepe, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Mehmet P ATAGUNDUZ, MD
- Email: pamiratagunduz@marmara.edu.tr
- Phone: +90(530) 939 45 94
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Surface topography and spine damage in radiographic axial spondyloarthritis
This study tests whether a radiation-free 3D surface topography method can reflect spine damage and sagittal balance in adults with radiographic axial spondyloarthritis.
-
Pain patterns in rheumatic diseases: see if pain works differently in patients and healthy people
This observational study tests how pain is experienced and measured in people with rheumatic diseases compared with healthy volunteers.
-
Imaging in Inflammatory Heart Diseases linked to autoimmune disorders
This study tests how well multimodality imaging (CMR, echocardiography, and PET) detects inflammation in people with suspected inflammatory heart or autoimmune rheumatic diseases.
-
Comparing different flexibility rods for treating degenerative lumbar spine diseases
This study is testing whether different types of flexibility rods can help people with degenerative lumbar spine issues feel less back pain and improve their functionality over time.
-
Assessing IL-17 levels in patients with spondyloarthritis
This study is testing if measuring IL-17 levels in patients with active spondyloarthritis can help doctors choose the best biological treatment after other medications haven't worked.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.